| ATL | Achilles tendon lengthening; acute T-cell leukemia; adult T-cell leukemia; anterior tricuspid leafle... |
|---|---|
| atyp | atypical |
| ATZ | atypical transformation zone |
| FAMMM | familial atypical multiple mole-melanoma [syndrome] |
| PAP | pancreatitis-associated protein; Papanicolaou [test]; papaverine; passive-aggressive personality; pa... |
| atypical pseudocholinesterase | A genetic variant of cholinesterase that fails to catalyze the hydrolysis of succinylcholine. See: dibucaine number, fluoride number. (05 Mar 2000) |
|---|---|
| atypical trigeminal neuralgia | Periodic pain in any region of the face, teeth, tongue, and occasionally in the occipital or shoulder area, which lasts several minutes to several days but has no trigger point and lacks the paroxysmal character of tic douloureux. Synonym: atypical facial neuralgia. (05 Mar 2000) |
| atypical verrucous endocarditis | Verrucous endocarditis sometimes associated with disseminated lupus erythematosus. Synonym: atypical verrucous endocarditis, Libman-Sacks syndrome, nonbacterial verrucous endocarditis. (05 Mar 2000) |
| regressing atypical histiocytosis | A rare disease characterised clinically by multiple ulcerating cutaneous papules and nodules which show spontaneous regression; the skin is infiltrated by malignant-appearing histiocytes. (05 Mar 2000) |
| pneumonia, atypical interstitial, of cattle | A cattle disease of uncertain cause, probably an allergic reaction. (12 Dec 1998) |
| mycobacterium, atypical | So-called atypical species of the genus mycobacterium. They are also called tuberculoid bacilli, i.e.: m. Buruli (see m. Ulcerans), m. Chelonae, m. Duvalii, m. Flavescens, m. Fortuitum, m. Gilvum, m. Gordonae, m. Intracellulare (see mycobacterium avium complex), m. Kansasii (kansas), m. Marinum, m. Obuense, m. Scrofulaceum, m. Szulgai, m. Terrae, m. Ulcerans, m. Xenopi. (12 Dec 1998) |
| mycobacterium infections, atypical | Infections with so called atypical mycobacteria (tuberculoid bacilli): m. Kansasii (kansas), m. Marinum, m. Scrofulaceum, m. Flavescens, m. Gordonae, m. Obuense, m. Gilvum, m. Duvali, m. Szulgai, m. Intracellulare (see mycobacterium avium complex), m. Xenopi (littorale), m. Ulcerans, m. Buruli, m. Terrae, m. Fortuitum (minetti, giae), m. Chelonae. (12 Dec 1998) |
| primary atypical pneumonia | An acute systemic disease with involvement of the lungs, caused by Mycoplasma pneumoniae and marked by high fever, cough, relatively few physical signs, and scattered densities on X-rays; usually associated with development of cold agglutinins and antibodies to the bacteria. Synonym: atypical pneumonia, Eaton agent pneumonia, mycoplasmal pneumonia. (05 Mar 2000) |
| amorphous insulin zinc suspension | Sterile suspension of insulin in buffered water for injection, modified by the addition of zinc chloride such that the solid phase of the suspension is amorphous; it contains 40 or 80 units per ml; the duration of action is equivalent to that of insulin injection. Synonym: amorphous insulin zinc suspension, semilente insulin. (05 Mar 2000) |
| anti-insulin | A factor, usually an antibody, which antagonises the action of insulin. (05 Mar 2000) |
| anti-insulin antibody | A serologic blood test that is used to detect antibodies to insulin. This test is performed in insulin dependent diabetics who exhibit insulin resistance. The presence of antibodies denotes a positive result. (27 Sep 1997) |
| biphasic insulin | <protein> A type of insulin that is a mixture of intermediate- and fast-acting insulin. (09 Oct 1997) |
| receptors, insulin | Cell surface proteins that bind insulin and trigger intracellular changes which influence the behaviour of cells. The best understood physiological consequence of insulin receptor activation is increased transport of glucose into most cells, which controls the rate of carbohydrate metabolism. The insulin receptor is a multifunctional protein complex that has intrinsic tyrosine kinase activity and is capable of autophosphorylation. (12 Dec 1998) |
| receptors, insulin-like-growth factor I | Specific proteins on or in cells to which insulin-like growth factor I (somatomedin c) binds and thereby modifies the function of the cells. These receptors contain transmembrane and cytosolic domains, bind igf-I preferentially, and have high-affinity sites for igf-II. The alpha-subunit has a mw of 130 kD and the beta subunit possesses tyrosine kinase activity. (12 Dec 1998) |
| receptors, insulin-like-growth-factor II | Specific proteins on or in cells to which insulin-like growth factor II and mannose-6-phosphate bind and thereby modify the function of the cells. These receptors have a mw of 250 kD and possess no tyrosine kinase activity. (12 Dec 1998) |